Healthcare -
Biotechnology - NASDAQ - GB
$ 0.53
-1.85 %
$ 22.6 M
Market Cap
-3.12
P/E
ADAP - REVENUE
Revenue ADAP - Adaptimmune Therapeutics plc
60.3 M
LAST VALUE
213.10%
2 YEAR CAGR
0.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR